Cystic Neuroendocrine Tumors of the Pancreas (c-pNETs): A Single-Center Experience. Abstract #1430

Introduction: c-pNETs are rare and may be less aggressive than their solid counterparts
Aim(s): To report on the clinical manifestations and outcomes of patients (pts) treated for c-pNETs
Materials and methods: We identified all pts diagnosed with a c-pNET at Mayo Clinic from 1990 to 2014. Data on patient characteristics and outcomes of therapy were analyzed
Conference: 13th Annual ENETS conference (2016)
Category: Clinical cases/reports
Presenting Author: Dr. Thorvardur Halfdanarson

To read results and conclusion, please login ...

Further abstracts you may be interested in

#847 Incidental Pathological Finding of Pancreatic Non-Functioning Neuroendocrine Tumors
Introduction: Little is known about the incidental finding of non-functioning NETs (Neuroendocrine Tumors) during pancreatic surgery performed for other reasons or during pathological examination of the surgical sample.
Conference: 11th Annual ENETS Conference (2014)
Category: Surgical treatment
Presenting Author: Claudio Pasquali
#1282 Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Frequency, Treatment and Prognosis
Introduction: Data on peritoneal metastases (PM) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are scarce.
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: MD Ariana Madani
#1432 Neutrophil-Lymphocyte Ratio Predicts Survival in Pancreatic Neuroendocrine Tumors
Introduction: Although the prognostic role of neutrophil-lymphocyte ratio (NLR) has been confirmed in a variety of tumors, the prognostic role of NLR in pancreatic neuroendocrine tumors (PNETs) has not been examined.
Conference: 13th Annual ENETS conference (2016)
Category: Biomarkers
Presenting Author: Dr Kaizhou Jin
Authors: Luo G, Jin K, Liu C, Lu Y, ...
#1521 Metastatic Disease in Gastroenteropancreatic Neuroendocrine Cancer: Incidence, Treatment and Survival
Introduction: Data on patients with metastatic disease from GEP-NETs are rare.
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: MD Ariana Madani
#1832 Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results for a Single Institutional Surgical Series
Introduction: Cystic pancreatic neuroendocrine tumors (CPanNET) are an uncommon variant of pancreatic neuroendocrine tumors (PanNETs). Due to their rarity, there is a lack of knowledge with regards to clinical features and prognosis.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: MD Marco Miotto
Keywords: cystic